REUTERS – Wall Street opened lower on Thursday as Apple weighed on the major indexes and Celgene led a fall in biotech stocks, more than offsetting encouraging economic data.All the 10 major S&P sectors were down, with the technology index retreating 1.1 percent. The Nasdaq biotech index dropped 1.7 percent.Apple fell 2.3 percent to $125.70 and was the biggest drag […]
Benchmarks finished in negative territory on Wednesday on weak GDP report while Fed retained the data-dependent stance regarding rate hike. The U.S. economy expanded at a slower pace in the first quarter due to severe winter weather, major disputes in ports and stronger dollar that adversely affected export-oriented companies. Meanwhile, investors continued to keep an eye on first quarter earnings […]
It’s been a turbulent few days for the biotech sector with the NASDAQ Biotechnology Index declining 5.46% over the last five trading days. A major part of this decline was recorded on Monday as the sector reacted to negative pipeline updates from companies like Amgen (AMGN – Analyst Report) and Celladon (CLDN – Snapshot Report). Meanwhile, Biogen’s (BIIB – Analyst […]
Related GPROGoPro: Market Expecting Nearly 9% Move Following EarningsEverything The Street Has Said About GoProTaser, Digital Ally Shares Up Amid Baltimore Clashes(Investor’s Business Daily)GoPro Inc (NASDAQ: GPRO) traders are scrambling to decide how to play the company’s earnings report coming after the market close. Fundamental and technical traders have likely been pouring over countless metrics for days trying to determine […]
Benchmarks ended the first trading session of the week in the red led by losses in biotech shares. Meanwhile, investors refrained from placing big bets ahead of the Federal Reserve meeting, which begins today. Investors also kept an eye on first quarter earnings results.For a look at the issues currently facing the markets, make sure to read today’s Ahead of […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Related CNCOppenheimer Boosting Targets In Healthcare On ‘Exposure To Interest Rate Changes’8 Managed Care Stocks To Watch In Earnings Season’Non-Cyclical Consumer Healthcare’: How This Sector Will Create Long-Term Wealth(Seeking Alpha)Related Biotech: Anatomy Of An Investing Mania?Bind Therapeutics Rallies Off Oppenheimer RatingIn separate reports, Oppenheimer analysts commented on the pipelines of two Biotech majors – Centene Corp (NYSE: CNC) and BIND […]
Impending Stock Market Top – Trend Forecast Summer 2015Stock-Markets / Stock Markets 2015Apr 26, 2015 – 09:55 PM GMTBy: Toby_ConnorAs I have been expecting for almost a year now the Nasdaq has finally reached its all-time highs at 5100.That being said, the 5100 level is a huge resistance zone. It has held for 15 years. The bull is very mature […]
In last week’s Fakeout or Breakout? I made the case based on the technical evidence that “despite Friday’s drop, I expect last week’s highs in the major averages to be surpassed in the coming weeks.” As you may recall, the S&P 500 was down over 1% on Friday April 17 and the bearish sentiment spiked.In last Thursday’s trading, the NYSE […]
Netty Idayu Ismail of Bloomberg reports, Hedge Fund That Made 18% on Dollar Strength Now Bets on Drop:
Charlie Chan, a former Credit Suisse Group AG proprietary trader who now runs his own hedge fund, reduced bets the dollar will strengthen and added trades that would profit from a decline.Chan said he trimmed his fund’s long dollar position versus the yen […]
